Taysha Gene Therapies is a biopharmaceutical firm developing treatments for inherited neurological disorders using adeno-associated virus technology. The company specializes in gene therapy approaches targeting single-gene diseases affecting the central nervous system. Based in Dallas, Texas, Taysha works on bringing these therapeutic candidates toward commercialization.

entry readiness 68 · GOOD SETUP · exit proximity 0

Value area 4.85–6.75 · 90% of 120d volume overhead · heavy supply